1
|
Alqashqri HS, Siddiqi A, Albar HT, Alfalogy EH, Hariri NH, Alhindi YZ, Alshanberi AM, Alsanosi SM, Falemban AH. Prescribing Renally Inappropriate Medication to Hospitalized Geriatric Patients in Makkah, Saudi Arabia. Int J Gen Med 2024; 17:1755-1764. [PMID: 38706746 PMCID: PMC11070154 DOI: 10.2147/ijgm.s462135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2024] [Accepted: 04/24/2024] [Indexed: 05/07/2024] Open
Abstract
Introduction As a result of the physiological decline in renal function that comes with age and the common failure to recognise renal insufficiency, older adults aged 65 and above are at increased risk of receiving medications that are inappropriate for their level of renal function which in turn lead to increased risk of adverse effects. Little is known about how many older adults receive medications that are inappropriate for their level of renal function. This study aimed to determine the prevalence of renally inappropriate medications in elderly adults by reviewing patient files and evaluating the appropriateness of medication doses relative to renal function in patients aged ≥ 65 years at inpatient healthcare departments. Methods A retrospective cross-sectional study of patients aged ≥ 65 years was conducted, covering cases from 2015 to 2021. Patient's medical records were reviewed, their renal function and medications lists were evaluated, determined whether they had been prescribed at least one renally inappropriate medication based on drug-dosing recommendations for different degrees of renal function. Results A total of 317 elderly inpatients were included, 10% of whom had received inappropriate doses relative to their renal function. Glomerular filtration rate was associated with inappropriate dosing in this study. Of the patients CKD stage 5, 36.8% had at least one drug administered at an inappropriate dose, while this figure was 6.5% among the patients at CKD stage 1; this difference was statistically significant (p = 0.001). Conclusion A notable portion of older adults may be at risk of adverse effects due to inappropriate medication dosing related to their renal function. Further studies with large samples, drug use analyses based on comprehensive geriatric references and a prioritisation of actual outcomes over potential outcomes are needed to further determine elderly adults' exposure to inappropriate drugs.
Collapse
Affiliation(s)
- Hamsah S Alqashqri
- Department of Community Medicine and Pilgrims Health Care, Faculty of Medicine, Umm Al Qura University, Makkah, Saudi Arabia
| | - Ahmed Siddiqi
- Department of Internal Medicine, National Guard Hospital, Jeddah, Saudi Arabia
| | - Halah T Albar
- Department of Physiology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
| | - Enas H Alfalogy
- Department of Community Medicine and Pilgrims Health Care, Faculty of Medicine, Umm Al Qura University, Makkah, Saudi Arabia
- Family Medicine, Faculty of Medicine, Suez-Canal University, Ismailia, Egypt
| | - Nahla H Hariri
- Department of Community Medicine and Pilgrims Health Care, Faculty of Medicine, Umm Al Qura University, Makkah, Saudi Arabia
| | - Yosra Z Alhindi
- Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al Qura University, Makkah, Saudi Arabia
| | - Asim M Alshanberi
- Department of Community Medicine and Pilgrims Health Care, Faculty of Medicine, Umm Al Qura University, Makkah, Saudi Arabia
| | - Safaa M Alsanosi
- Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al Qura University, Makkah, Saudi Arabia
| | - Alaa H Falemban
- Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al Qura University, Makkah, Saudi Arabia
| |
Collapse
|
2
|
El Said M, Alshanberi AM, Abouelmagd F, Shaikhomer M, Hassan FE. Insight on the hepatitis B virus and host immune mechanisms in the context of occult hepatitis. Egypt J Immunol 2024; 31:87-105. [PMID: 38224274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2024]
Abstract
Hepatitis B virus infection is the 10th leading cause of death around the world. Occult HBV infection (OBI) represents those with a viral load of < 104 IU/ml. Among permanent blood recipients, OBI appears to be the most common cause of posttransfusion hepatitis. Moreover, OBI may reduce hepatitis C virus (HCV) treatment responsiveness in people with chronic HCV infection, and OBI may become acutely reactivated when on immunosuppression or potentially contribute to chronic liver disease. Since most previous studies used either small sample sizes, diverse populations, or were cross-sectional in design, it is possible that using multiple techniques with varying sensitivity for HBV DNA measurement in the liver or serum will shed light on discrepancies in the impact of OBI in cases with chronic liver disease. The purpose of this research is to review many elements of OBI, such as its prevalence, the hepatitis B virus and host immune mechanisms, diagnostic procedures, clinical implications, therapy, and prevention strategies.
Collapse
Affiliation(s)
- Manal El Said
- Department of Microbiology and Infection Prevention and Control Unit, Theodor Bilharz Research Institute, Giza 12411, Egypt
- General Medicine Practice Program, Department of Microbiology, Batterjee Medical College, Jeddah 21442, Saudi Arabia
| | - Asim M Alshanberi
- Department of Community Medicine and Pilgrims Health Care, Umm Alqura University, Makkah, Saudi Arabia
| | - Faten Abouelmagd
- General Medicine Practice Program, Department of Microbiology, Batterjee Medical College, Jeddah 21442, Saudi Arabia
- Department of Medical Parasitology, Faculty of Medicine, Sohag University, Sohag, Egypt
| | - Mohammed Shaikhomer
- Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Fatma E Hassan
- General Medicine Practice Program, Department of Physiology, Batterjee Medical College, Jeddah 21442, Saudi Arabia
- Department of Medical Physiology, Kasr Alainy, Faculty of Medicine, Cairo University, Giza11562, Egypt
| |
Collapse
|
3
|
Al Eissa MM, Almsned F, AlQurashi R, Alsanosi SM, Alshanberi AM, Saleh N, Alsaieedi AA, Alkharji RR, Halawani AJ. Perceptions of Saudis Toward Participating in the COVID-19 Convalescent Plasma Clinical Trial. Cureus 2023; 15:e48879. [PMID: 38106720 PMCID: PMC10724773 DOI: 10.7759/cureus.48879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/15/2023] [Indexed: 12/19/2023] Open
Abstract
Introduction The COVID-19 pandemic has been a major public health and economic issue worldwide. Even though vaccines have been developed to reduce the spread of the infection, treating patients remains a significant challenge. This study aims to measure the perceptions of Saudis toward participating in the COVID-19 Convalescent Plasma Clinical Trial. Method A cross-sectional study measuring the perceptions of Saudis toward participating in the COVID-19 Convalescent Plasma Clinical Trial was conducted with participants who had recovered from COVID-19. The study used an online questionnaire covering variables related to demographics, awareness, attitudes, perceptions, and plans for improvement. Results A sample of 1,051 participants participated in the questionnaire. A total of 85% had recovered from COVID-19, only 2.76% had participated in clinical trials before, and 83.44% would participate if they were advised or knew about them. The participants showed a high level of education, with 88% having obtained a degree and most used social media. The results can be biased toward the participants who get their knowledge from social media and hope to learn about things on social media. The gap in knowledge about clinical trials among the participants indicated that certain age groups could be targeted through channels where they communicate the most. Conclusion Engaging the community in clinical trials and educating others about their value by sharing experiences would help promote clinical trials and activate donations.
Collapse
Affiliation(s)
- Mariam M Al Eissa
- Medical School, Alfaisal University, Riyadh, SAU
- Molecular Genetics, Public Health Authority, Public health Lab, Riyadh, SAU
| | - Fahad Almsned
- Epidemiology and Public Health, King Fahad Specialist Hospital, Research Centre, Dammam, SAU
- Research and Development, NovoGenomics, Riyadh, SAU
| | - Raghad AlQurashi
- Molecular Genetics, Public Health Lab, Public Health Authority, Riyadh, SAU
| | - Safaa M Alsanosi
- Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, Makkah, SAU
- Cardiovascular and Metabolic Health, University of Glasgow, BHF Glasgow Cardiovascular Research Centre, Glasgow, GBR
| | - Asim M Alshanberi
- Community Medicine, Faculty of Medicine, Umm Alqura University, Makkah, SAU
- General Medicine Practice, Batterjee Medical College, Jeddah, SAU
| | - Nada Saleh
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU
- King Abdullah International Medical Research Centre, Ministry of National Guard Health Affairs, Riyadh, SAU
| | - Ahdab A Alsaieedi
- Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, SAU
- Vaccines and Immunotherapy Unit, King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, SAU
| | - Reem R Alkharji
- Research, Princess Nourah Bint Abdulrahman University Health Sciences, Research Centre, Riyadh, SAU
| | - Amr J Halawani
- Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, SAU
| |
Collapse
|
4
|
Mousa AH, Ibrahim AS, Alsayed AW, Albukhari ZZ, Mogharbel A, Alshanberi AM, Albar NY. Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report. Ann Med Surg (Lond) 2023; 85:3012-3016. [PMID: 37363471 PMCID: PMC10289717 DOI: 10.1097/ms9.0000000000000724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2022] [Accepted: 04/15/2023] [Indexed: 06/28/2023] Open
Abstract
Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. Case presentation Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. Clinical discussion The surgical cytoreduction or 'debulking' technique is the main treatment option started in individuals with High Grade Serous Ovarian CanceR. This surgical strategy aims to completely remove all disseminated tumor masses that are present in the patient's peritoneal cavity on a macroscopic level. Conclusion In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago.Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago.
Collapse
Affiliation(s)
- Ahmed H. Mousa
- College of Medicine and Surgery, Batterjee Medical College, Jeddah, Saudi Arabia
| | | | | | - Zain Z. Albukhari
- College of Medicine and Surgery, Batterjee Medical College, Jeddah, Saudi Arabia
| | | | - Asim M. Alshanberi
- College of Medicine and Surgery, Batterjee Medical College, Jeddah, Saudi Arabia
- Department of Community Medicine and Pilgrims Health Care, Umm Al-Qura University, Makkah
| | | |
Collapse
|
5
|
Radwan RA, Alwafi HH, Alhindi YZ, Falemban AH, Ansari SA, Alshanberi AM, Ayoub NA, Alsanosi SM. Patterns of Caffeine Consumption in Western Province of Saudi Arabia. Pharmacognosy Res 2022. [DOI: 10.5530/pres.14.3.39] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|